華夏健康產業(01143.HK)接獲傳訊令狀被申索2000萬港元
格隆匯10月23日丨華夏健康產業(01143.HK)公告,公司於2019年10月21日已接獲原告人Bright Mark Enterprises Limited(原告人)透過香港特別行政區高等法院原訟法庭對被告人公司發出的傳訊令狀。
原告人向公司提出申索金額2000萬港元,相當於融資協議項下的貸款金,外加利息及費用。鑑於訴訟程序處於初步階段,董事會認為目前評估其對公司的潛在影響不切實際,且集團維持正常經營活動。公司正就法律訴訟程序尋求法律意見。公司將會於適當時間就法律訴訟程序相關的任何重大發展另行刊發公告。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.